Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Sarcoma
  • Sarcoma Metastatic
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 16 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04076579
Collaborators
  • Janssen Scientific Affairs, LLC
  • AstraZeneca
Investigators
Principal Investigator: Rashmi Chugh, M.D. University of Michigan Rogel Cancer Center